FRANKLIN LAKES, N.J., July 23, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announces the first pharma-sponsored combination ...
Monash University researchers, alongside key partner Halozyme Therapeutics, report findings in support of shifting the way ...
Enable Injections, maker of manual and connected adhesive wearables for subcutaneously therapeutic delivery, has raised $50 million in a Series B round led by Sanofi, the company announced today. ORI ...
Previously lecanemab was only approved as an SC injection for maintenance dosing, following an initial 18 month IV phase.
Subcutaneous (subQ or SQ) injections are shots given in the fatty tissue layer (subcutaneous fat) under your skin. Your skin has many layers, and the subcutaneous layer is beneath the epidermis and ...
The "Connected Drug Delivery Devices Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Device, Mode of Connectivity, Route of Administration, Therapeutic Area and ...
(RTTNews) - Healthcare innovation company Enable Injections, Inc. and biotechnology company Swedish Orphan Biovitrum AB or Sobi, announced Thursday an international development and distribution ...
Subcutaneous immunotherapy injections work the same way as their intravenous counterparts — by changing or enhancing a person’s immune responses to cancer. Immunotherapy for cancer is a broad category ...
Dr. Balazs Halmos discusses the significance of the FDA approval of the subcutaneous injection formulation of Opdivo for patients with solid tumors. The Food and Drug Administration (FDA) approval of ...
The BD Libertas™ Wearable Injector is an innovative, prefilled, patient ready-to-use drug delivery system iii designed to enable delivery of complex biologics via subcutaneous injection. The biologics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results